Coronavirus Thread: Worldwide Pandemic

barese

Pro
Joined
Dec 11, 2013
Messages
897
Reputation
167
Daps
1,578
how is no one talking about this?

https://www.thecoli.com/threads/wuh...ims-of-coronavirus-says-us-government.827039/

I'm not seeing any new facts in this interview.
If you don't consider the supposed impossibility of a spillover and immediate inter-human infection. Like there was no original SARS, that did just that.
And a whole bunch of other viruses, and
I suggest reading Spillover by David Quammen that describes a lot of spillovers through history.


my jaw straight up dropped when I was watching this epic bombshell live

felt like a scene in an apocalyptic film....


:smoker:
Good National Geografic article:
Why misinformation about COVID-19’s origins keeps going viral

Bill Maher should interview some Ivy League virology professors:
 

null

...
Joined
Nov 12, 2014
Messages
33,969
Reputation
6,665
Daps
52,406
Reppin
UK, DE, GY, DMV
https://www.thecoli.com/threads/wuh...ims-of-coronavirus-says-us-government.827039/

I'm not seeing any new facts in this interview.
If you don't consider the supposed impossibility of a spillover and immediate inter-human infection. Like there was no original SARS, that did just that.
And a whole bunch of other viruses, and
I suggest reading Spillover by David Quammen that describes a lot of spillovers through history.

Good National Geografic article:
Why misinformation about COVID-19’s origins keeps going viral

Bill Maher should interview some Ivy League virology professors:


Plenty of "new facts" here
MOI5Aar.png
. And in two additional discussions on that channel. But people do not want to hear it though.



They mentioned the furin cleavage channel in that Maher interview but they didn't go into details. That also said a couple of slightly odd things from what I remember namely, i. that only Cov II has a furin cleavage area and ii. he called it SARS Covid II (which would be an unusual thing for an expert to say, but maybe he was under pressure).

I bet you 100 USD paid by BTC that none of the links you posted discuss the genealogy of SARS Cov II in detail - i.e. amino acid level differences and where they came from (genealogy). None of the "it jumped from an animal" group ever do. I am so sure that your articles do not do this, that I am willing to make that bet without even checking first.
 

null

...
Joined
Nov 12, 2014
Messages
33,969
Reputation
6,665
Daps
52,406
Reppin
UK, DE, GY, DMV

☑︎#VoteDemocrat

The Original
Bushed
WOAT
Supporter
Joined
Dec 9, 2012
Messages
337,890
Reputation
-34,949
Daps
641,357
Reppin
The Deep State
:damn: :ohhh: :mindblown:

Glad I got my second shot two weeks ago :whew:



Israel Covid vaccine data shows extremely low rate of infections

Israel Covid vaccine data shows extremely low rate of infections
Only 0.04% of people caught virus a week after second dose and 0.002% needed hospital treatment
Oliver Holmes in Jerusalem
Sun 31 Jan 2021 07.32 EST First published on Sun 31 Jan 2021 06.46 EST

Shares
136




Joseph Zalman Kleinman, 92, a Holocaust survivor, receives his second dose of the Pfizer vaccine in Jerusalem. Photograph: Maya Alleruzzo/AP
Studies in Israel have offered tentative optimism on the effectiveness of vaccines in curbing the coronavirus pandemic, with initial data suggesting even the early stages of inoculation campaigns might have marked decreases in both hospital cases and infections.

With one in three Israelis having received at least one shot, a far higher fraction than anywhere else, the country of 9 million people provides a test case for the worldwide vaccine push.

The state’s 24/7 campaign has meant many vulnerable populations, including about 70% of over-60s, have already received the prescribed two doses of the Pfizer/BioNtech vaccine. The country is injecting up to 200,000 people a day, and last week made the jab available to anyone over 35. Secondary school students aged 16 to 18 are also included, in the hopes of allowing them to sit exams.

Israel’s health ministry released its first official results last week, showing that only 317 out of 715,425, or 0.04%, of people became infected a week after becoming fully vaccinated against the disease – the time when increased immunity is expected to kick in. Of the vaccinated people who were infected, 16 had to be treated in hospital, or 0.002% of the total.:ohhh:

One domestic healthcare provider, Maccabi Healthcare Services, released an encouraging smaller study on Thursday. It revealed that out of 163,000 Israelis given both shots, only 31 were infected, compared with nearly 6,500 infections among a control group of unvaccinated people.:ohhh:

Maccabi said the data suggested the vaccine was 92% effective, close to the 95% efficacy that Pfizer claims. “This is very, very good news,” Dr Anat Ekka Zohar, the vice-president of Maccabi, told local media.

Israel’s government has capitalised on its ability to run a rapid vaccination campaign, and analyse its impact on infections in real time, to persuade Pfizer to keep it steadily supplied with doses.

Earlier this month, the prime minister, Benjamin Netanyahu, said he had secured a commitment from the pharmaceutical company to bring forward deliveries in return for Israel providing “statistical data” – in effect making the country a mass test case to see how vaccines might halt the pandemic.

The country hopes to have vaccinated all over-16s by the end of March, and possibly earlier. Experts have said, however, that data from Israel is preliminary and could be misleading. With its vast variables and constantly changing scenarios, an entire society cannot act as a petri dish for a vaccine trial, they say.

“When you vaccinate nationwide, there’s lots of confounders,” said Eran Segal, a computational biologist at the Weizmann Institute. “This is not a trial. That’s the problem. We should be very cautious.”

Israel is up against a debilitating third wave of infections, with a national lockdown unable to significantly push down death rates. The government blames high infection rates on the more transmissible British variant of the virus. There has also been local resentment towards certain sections of the ultra-Orthodox Jewish community that have defied lockdown rules.

Yoav Kisch, the deputy health minister, said on Sunday there would be “a few weeks’ delay” to a national plan to reopen the economy, previously envisioned for early February.

Vaccine data could be influenced by both the lockdown, which may decrease infections, and the British variant, which likely has the opposite effect, in confusing and contrasting ways.

Meanwhile, the first people to receive the vaccine mostly come from vulnerable populations, who may have been more likely to take precautions, which also could skew the data. Preliminary research might show different results at different times as the number of people being vaccinated is continually changing, and hospitalisation usually occurs days after infection.

An intense global focus on signals from Israel has already led to controversy. Several million Palestinians living under Israeli occupation have not been vaccinated. :francis:On Sunday, Israel’s defence ministry said it had agreed to send 5,000 doses to immunise frontline Palestinian medical workers, a move that followed international pressure.

Separately, earlier this month, the country’s “coronavirus tsar” raised concerns that one shot of the Pfizer vaccine might be less effective than originally thought. The comments made news in the UK, where the government faces concerns that a policy to delay administering their second doses could backfire. However, Israel’s health ministry later said the comments had been taken out of context.

Last week’s health ministry figures may provide further concern for the UK policy. It showed that 42% of Israel’s 834 critically ill patients had already received one shot of the Pfizer vaccine. That figure dropped to 2% after the second jab.:ohhh:

While acknowledging the limitations of data coming out of Israel, Segal does see possible hope in one potential indicator – the percentage of people over 60 who have become critically ill. As a fraction of the total population, that group, which has largely been vaccinated, is decreasing, a trend not seen during previous lockdowns when inoculations were unavailable.

“There are definitely some positive indications,” he said. “We should begin to see numbers going down, both critically ill and infections. Definitely the critically ill.”
 
Top